Statements (60)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:pharmaceuticals
|
| gptkbp:approves |
gptkb:2004
|
| gptkbp:brand |
gptkb:Duo_Neb
|
| gptkbp:class |
gptkb:Spider-Man
anticholinergic |
| gptkbp:clinical_trial |
NCT00012345
NCT00067890 |
| gptkbp:clinical_use |
acute asthma attacks
prevention of bronchospasm maintenance therapy for COPD |
| gptkbp:contains |
gptkb:ipratropium_bromide
albuterol |
| gptkbp:contraindication |
urinary retention
hypersensitivity to albuterol narrow-angle glaucoma prostatic hypertrophy hypersensitivity to ipratropium bromide |
| gptkbp:dosage_form |
nebulizer solution
|
| gptkbp:drug_interactions |
MAO inhibitors
beta-blockers |
| gptkbp:effective_date |
FDA approved
|
| gptkbp:financial_support |
do not exceed prescribed dose
consult doctor if symptoms worsen |
| gptkbp:form |
aerosol
solution for nebulization |
| https://www.w3.org/2000/01/rdf-schema#label |
Duo Neb
|
| gptkbp:indication |
bronchodilator therapy
|
| gptkbp:ingredients |
gptkb:albuterol_sulfate
gptkb:ipratropium_bromide |
| gptkbp:manufacturer |
gptkb:Teva_Pharmaceuticals
|
| gptkbp:mechanism_of_action |
inhibits acetylcholine
relaxes bronchial muscles |
| gptkbp:packaging |
vials
|
| gptkbp:patient_education |
report any severe side effects immediately
rinse mouth after use use with nebulizer only |
| gptkbp:pharmacokinetics |
excreted in urine
metabolized in the liver rapid onset of action duration of action 4-6 hours |
| gptkbp:related_products |
gptkb:Combivent
gptkb:Respimat |
| gptkbp:route_of_administration |
inhalation
|
| gptkbp:service_frequency |
as prescribed by physician
|
| gptkbp:side_effect |
dizziness
headache nausea cough dry mouth nervousness tremors increased heart rate palpitations throat irritation |
| gptkbp:storage |
room temperature
protect from light |
| gptkbp:used_for |
gptkb:asthma
gptkb:chronic_obstructive_pulmonary_disease_(COPD) |
| gptkbp:bfsParent |
gptkb:Valeant_Pharmaceuticals
|
| gptkbp:bfsLayer |
6
|